The company expects to launch the product — phytonadione injectable emulsion USP, 10 mg/mL single dose ampoules — through its marketing partners in the near future. Shares of Gland Pharma Ltd ended at ₹1,779.95, up by ₹16.50, or 0.94%, on the BSE.
The company expects to launch the product — phytonadione injectable emulsion USP, 10 mg/mL single dose ampoules — through its marketing partners in the near future. Shares of Gland Pharma Ltd ended at ₹1,779.95, up by ₹16.50, or 0.94%, on the BSE.